Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy against Glioblastoma and Grade 4 Astrocytoma

2.

Salgado

R

,

Denkert

C

,

Demaria

S

,

Sirtaine

N

,

Klauschen

F

,

Pruneri

G

, et al.

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

.

Ann Oncol

.

2015

;

26

(

2

):

259

–

71

.

3.

Komohara

Y

,

Ohnishi

K

,

Kuratsu

J

,

Takeya

M

.

Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas

.

J Pathol

.

2008

;

216

(

1

):

15

–

24

.

4.

Wainwright

DA

,

Dey

M

,

Chang

A

,

Lesniak

MS

.

Targeting Tregs in malignant brain cancer: overcoming IDO

.

Front Immunol

.

2013

;

4

:

116

.

5.

Yang

S

,

Liu

Y

,

Li

MY

,

Ng

CSH

,

Yang

SL

,

Wang

S

, et al.

FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer

.

Mol Cancer

.

2017

;

16

(

1

):

124

.

6.

Wang

J

,

Gong

R

,

Zhao

C

,

Lei

K

,

Sun

X

,

Ren

H

.

Human FOXP3 and tumour microenvironment

.

Immunology

.

2023

;

168

(

2

):

248

–

55

.

7.

Su

P

,

Jiang

L

,

Zhang

Y

,

Yu

T

,

Kang

W

,

Liu

Y

, et al.

Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer

.

Cancer Cell Int

.

2022

;

22

(

1

):

290

.

8.

Saleh

R

,

Elkord

E

.

FoxP3+ T regulatory cells in cancer: prognostic biomarkers and therapeutic targets

.

Cancer Lett

.

2020

;

490

:

174

–

85

.

9.

van Hooren

L

,

Handgraaf

SM

,

Kloosterman

DJ

,

Karimi

E

,

van Mil

LWHG

,

Gassama

AA

, et al.

CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma

.

Nat Cancer

.

2023

;

4

(

5

):

665

–

81

.

10.

Sayour

EJ

,

McLendon

P

,

McLendon

R

,

De Leon

G

,

Reynolds

R

,

Kresak

J

, et al.

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma

.

Cancer Immunol Immunother

.

2015

;

64

(

4

):

419

–

27

.

11.

Peng

LS

,

Zhuang

Y

,

Shi

Y

,

Zhao

YL

,

Wang

TT

,

Chen

N

, et al.

Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer

.

Cancer Immunol Immunother

.

2012

;

61

(

11

):

2183

–

92

.

12.

Khan

F

,

Pang

L

,

Dunterman

M

,

Lesniak

MS

,

Heimberger

AB

,

Chen

P

.

Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy

.

J Clin Investig

.

2023

;

133

(

1

):

e163446

.

13.

Böttcher

C

,

Schlickeiser

S

,

Sneeboer

MAM

,

Kunkel

D

,

Knop

A

,

Paza

E

, et al.

Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry

.

Nat Neurosci

.

2019

;

22

(

1

):

78

–

90

.

14.

Jurga

AM

,

Paleczna

M

,

Kuter

KZ

.

Overview of general and discriminating markers of differential microglia phenotypes

.

Front Cell Neurosci

.

2020

;

14

:

198

.

15.

Tremble

LF

,

Forde

PF

,

Soden

DM

.

Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges

.

Cancer Immunol Immunother

.

2017

;

66

(

12

):

1509

–

27

.

16.

Liu

X

,

Hogg

GD

,

Zuo

C

,

Borcherding

NC

,

Baer

JM

,

Lander

VE

, et al.

Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity

.

Cancer Cell

.

2023

;

41

(

6

):

1073

–

90.e12

.

17.

Vidyarthi

A

,

Agnihotri

T

,

Khan

N

,

Singh

S

,

Tewari

MK

,

Radotra

BD

, et al.

Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity

.

Cancer Immunol Immunother

.

2019

;

68

(

12

):

1995

–

2004

.

18.

Annovazzi

L

,

Mellai

M

,

Bovio

E

,

Mazzetti

S

,

Pollo

B

,

Schiffer

D

.

Microglia immunophenotyping in gliomas

.

Oncol Lett

.

2018

;

15

(

1

):

998

–

1006

.

19.

Müller

S

,

Kohanbash

G

,

Liu

SJ

,

Alvarado

B

,

Carrera

D

,

Bhaduri

A

, et al.

Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment

.

Genome Biol

.

2017

;

18

(

1

):

234

.

20.

WHO Classification of Tumours Editorial Board

.

World Health Organization classification of tumours of the central nervous system

. 5th ed.

Lyon

:

International Agency for Research on Cancer

;

2021

.

21.

Gállego Pérez-Larraya

J

,

Garcia-Moure

M

,

Labiano

S

,

Patiño-García

A

,

Dobbs

J

,

Gonzalez-Huarriz

M

, et al.

Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma

.

N Engl J Med

.

2022

;

386

(

26

):

2471

–

81

.

22.

Abengozar-Muela

M

,

Esparza

MV

,

Garcia-Ros

D

,

Vásquez

CE

,

Echeveste

JI

,

Idoate

MA

, et al.

Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence

.

Mod Pathol

.

2020

;

33

(

12

):

2507

–

19

.

23.

Widodo

SS

,

Hutchinson

RA

,

Fang

Y

,

Mangiola

S

,

Neeson

PJ

,

Darcy

PK

, et al.

Toward precision immunotherapy using multiplex immunohistochemistry and in silico methods to define the tumor immune microenvironment

.

Cancer Immunol Immunother

.

2021

;

70

(

7

):

1811

–

20

.

24.

Geraghty

T

,

Rajagopalan

A

,

Aslam

R

,

Pohlman

A

,

Venkatesh

I

,

Zloza

A

, et al.

Positive allosteric modulation of CD11b as a novel therapeutic strategy against lung cancer

.

Front Oncol

.

2020

;

10

:

748

.

25.

Lamers

C

,

Plüss

CJ

,

Ricklin

D

.

The promiscuous profile of complement receptor 3 in ligand binding, immune modulation, and pathophysiology

.

Front Immunol

.

2021

;

12

:

662164

.

26.

Broz

ML

,

Binnewies

M

,

Boldajipour

B

,

Nelson

AE

,

Pollack

JL

,

Erle

DJ

, et al.

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

.

Cancer Cell

.

2014

;

26

(

5

):

638

–

52

.

27.

Schmid

MC

,

Khan

SQ

,

Kaneda

MM

,

Pathria

P

,

Shepard

R

,

Louis

TL

, et al.

Integrin CD11b activation drives anti-tumor innate immunity

.

Nat Commun

.

2018

;

9

(

1

):

5379

.

28.

Gottlieb

A

,

Toledano-Furman

N

,

Prabhakara

KS

,

Kumar

A

,

Caplan

HW

,

Bedi

S

, et al.

Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations

.

Sci Rep

.

2022

;

12

(

1

):

6289

.

29.

Donson

AM

,

Birks

DK

,

Schittone

SA

,

Kleinschmidt-DeMasters

BK

,

Sun

DY

,

Hemenway

MF

, et al.

Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors

.

J Immunol

.

2012

;

189

(

4

):

1920

–

7

.

30.

Geisenberger

C

,

Mock

A

,

Warta

R

,

Rapp

C

,

Schwager

C

,

Korshunov

A

, et al.

Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain

.

Acta Neuropathol

.

2015

;

130

(

3

):

419

–

34

.

31.

El Andaloussi

A

,

Lesniak

MS

.

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

.

Neuro Oncol

.

2006

;

8

(

3

):

234

–

43

.

32.

Díaz

LR

,

Saavedra-López

E

,

Romarate

L

,

Mitxitorena

I

,

Casanova

PV

,

Cribaro

GP

, et al.

Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma

.

JCI Insight

.

2018

;

3

(

18

):

e120757

.

33.

Mauldin

IS

,

Jo

J

,

Wages

NA

,

Yogendran

LV

,

Mahmutovic

A

,

Young

SJ

, et al.

Proliferating CD8+ T cell infiltrates are associated with improved survival in glioblastoma

.

Cells

.

2021

;

10

(

12

):

3378

.

34.

Martinez-Lage

M

,

Lynch

TM

,

Bi

Y

,

Cocito

C

,

Way

GP

,

Pal

S

, et al.

Immune landscapes associated with different glioblastoma molecular subtypes

.

Acta Neuropathol Commun

.

2019

;

7

(

1

):

203

.

35.

Mezheyeuski

A

,

Backman

M

,

Mattsson

J

,

Martín-Bernabé

A

,

Larsson

C

,

Hrynchyk

I

, et al.

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

.

EBioMedicine

.

2023

;

88

:

104452

.

36.

Wang

S

,

Wang

J

,

Chen

Z

,

Luo

J

,

Guo

W

,

Sun

L

, et al.

Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance

.

NPJ Precis Oncol

.

2024

;

8

(

1

):

31

.

37.

Sánchez-Paulete

AR

,

Mateus-Tique

J

,

Mollaoglu

G

,

Nielsen

SR

,

Marks

A

,

Lakshmi

A

, et al.

Targeting macrophages with CAR T cells delays solid tumor progression and enhances antitumor immunity

.

Cancer Immunol Res

.

2022

;

10

(

11

):

1354

–

69

.

38.

Mantovani

A

,

Allavena

P

,

Marchesi

F

,

Garlanda

C

.

Macrophages as tools and targets in cancer therapy

.

Nat Rev Drug Discov

.

2022

;

21

(

11

):

799

–

820

.

39.

Hodges

TR

,

Ott

M

,

Xiu

J

,

Gatalica

Z

,

Swensen

J

,

Zhou

S

, et al.

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

.

Neuro Oncol

.

2017

;

19

(

8

):

1047

–

57

.

40.

Omuro

A

,

Vlahovic

G

,

Lim

M

,

Sahebjam

S

,

Baehring

J

,

Cloughesy

T

, et al.

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

.

Neuro Oncol

.

2018

;

20

(

5

):

674

–

86

.

41.

Schalper

KA

,

Rodriguez-Ruiz

ME

,

Diez-Valle

R

,

López-Janeiro

A

,

Porciuncula

A

,

Idoate

MA

, et al.

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

.

Nat Med

.

2019

;

25

(

3

):

470

–

6

.

42.

Peranzoni

E

,

Lemoine

J

,

Vimeux

L

,

Feuillet

V

,

Barrin

S

,

Kantari-Mimoun

C

, et al.

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment

.

Proc Natl Acad Sci U S A

.

2018

;

115

(

17

):

E4041

–

50

.

43.

Dustin

ML

.

T-cell activation through immunological synapses and kinapses

.

Immunol Rev

.

2008

;

221

:

77

–

89

.

44.

Zhu

M

,

Bai

L

,

Liu

X

,

Peng

S

,

Xie

Y

,

Bai

H

, et al.

Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages

.

J Immunother Cancer

.

2022

;

10

(

12

):

e005610

.

45.

Elmore

MR

,

Najafi

AR

,

Koike

MA

,

Dagher

NN

,

Spangenberg

EE

,

Rice

RA

, et al.

Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain

.

Neuron

.

2014

;

82

(

2

):

380

–

97

.

46.

Butowski

N

,

Colman

H

,

De Groot

JF

,

Omuro

AM

,

Nayak

L

,

Wen

PY

, et al.

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

.

Neuro Oncol

.

2016

;

18

(

4

):

557

–

64

.

47.

Backman

M

,

Strell

C

,

Lindberg

A

,

Mattsson

JSM

,

Elfving

H

,

Brunnström

H

, et al.

Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer

.

Eur J Cancer

.

2023

;

185

:

40

–

52

.

48.

Massi

D

,

Rulli

E

,

Cossa

M

,

Valeri

B

,

Rodolfo

M

,

Merelli

B

, et al.

The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors

.

J Immunother Cancer

.

2019

;

7

(

1

):

308

.

49.

Blakstad

H

,

Brekke

J

,

Rahman

MA

,

Arnesen

VS

,

Miletic

H

,

Brandal

P

, et al.

Survival in a consecutive series of 467 glioblastoma patients: association with prognostic factors and treatment at recurrence at two independent institutions

.

PLoS One

.

2023

;

18

(

2

):

e0281166

.

50.

Voduc

D

,

Kenney

C

,

Nielsen

TO

.

Tissue microarrays in clinical oncology

.

Semin Radiat Oncol

.

2008

;

18

(

2

):

89

–

97

.

51.

Aust

S

,

Bachmayr-Heyda

A

,

Pils

D

,

Zhao

L

,

Tong

W

,

Berger

A

, et al.

Determination of tumor-infiltrating CD8+ lymphocytes in human ovarian cancer

.

Int J Gynecol Pathol

.

2013

;

32

(

3

):

269

–

76

.

52.

Lee

ATJ

,

Chew

W

,

Wilding

CP

,

Guljar

N

,

Smith

MJ

,

Strauss

DC

, et al.

The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma

.

Sci Rep

.

2019

;

9

(

1

):

14602

.

53.

Elfving

H

,

Thurfjell

V

,

Mattsson

JSM

,

Backman

M

,

Strell

C

,

Micke

P

.

Tumor heterogeneity confounds lymphocyte metrics in diagnostic lung cancer biopsies

.

Arch Pathol Lab Med

.

2024

;

148

(

1

):

e18

–

24

.

54.

Schmidt

LH

,

Biesterfeld

S

,

Kümmel

A

,

Faldum

A

,

Sebastian

M

,

Taube

C

, et al.

Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue

.

Anticancer Res

.

2009

;

29

(

1

):

201

–

9

.